Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

CPI-1205,Combined w/Enzalutamide or Abiraterone/Prednisone Patients w/Met Castration Resistant Prost

Protocol: OSU-18245

Full Title

ProSTAR: A Phase 1b/2 Study of CPI-1205, a Small Molecule Inhibitor of EZH2, Combined with Enzalutamide or Abiraterone/Prednisone in Patients with Metastatic Castration Resistant Prostate Cancer

Genitourinary Cancers Prostate Cancer